---
figid: PMC12123228__fphar-16-1585061-g001
figtitle: BCR signaling pathway and mechanism of action of BTKi
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12123228
filename: fphar-16-1585061-g001.jpg
figlink: /pmc/articles/PMC12123228/figure/F1/
number: F1
caption: 'BCR signaling pathway and mechanism of action of BTKi. B-cell receptors
  consist of transmembrane immunoglobulin (Igα/β) and CD19, which are responsible
  for antigen recognition and activation of downstream signaling cascades. IP3-Ca2+-NFAT
  pathway: promotes Ca2+ release, activates NFAT (nuclear factor-activated T cells),
  and regulates gene transcription. DAG-PKC pathway: activation of PKC (protein kinase
  C), further activation of NF-κB and MAPK/ERK, regulation of inflammatory response
  and cell survival. PI3K-AKT-mTOR pathway: promotes B cell survival and metabolic
  regulation through AKT and mTOR. BTKi inhibits BTK activity by covalently or non-covalently
  binding to Cys-481 (cysteine-481), blocking BCR signaling and inhibiting B cell
  survival. Image created with BioRender.com (accessed on 9 May 2025)'
papertitle: Investigation of the mechanism of hypertension caused by BTKi in the treatment
  of hematologic diseases
reftext: Jiayi Xu, et al. Front Pharmacol. 2025;16(NA).
year: '2025'
doi: 10.3389/fphar.2025.1585061
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media SA
keywords: BTKi | ibrutinib | oxidative stress | hypertension | cardiovascular diseases
automl_pathway: 0.9587929
figid_alias: PMC12123228__F1
figtype: Figure
redirect_from: /figures/PMC12123228__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12123228__fphar-16-1585061-g001.html
  '@type': Dataset
  description: 'BCR signaling pathway and mechanism of action of BTKi. B-cell receptors
    consist of transmembrane immunoglobulin (Igα/β) and CD19, which are responsible
    for antigen recognition and activation of downstream signaling cascades. IP3-Ca2+-NFAT
    pathway: promotes Ca2+ release, activates NFAT (nuclear factor-activated T cells),
    and regulates gene transcription. DAG-PKC pathway: activation of PKC (protein
    kinase C), further activation of NF-κB and MAPK/ERK, regulation of inflammatory
    response and cell survival. PI3K-AKT-mTOR pathway: promotes B cell survival and
    metabolic regulation through AKT and mTOR. BTKi inhibits BTK activity by covalently
    or non-covalently binding to Cys-481 (cysteine-481), blocking BCR signaling and
    inhibiting B cell survival. Image created with BioRender.com (accessed on 9 May
    2025)'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BCR
  - RN7SL263P
  - CD79A
  - CD19
  - LYN
  - SYK
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - IBTK
  - BLNK
  - BTK
  - PLCG2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MTOR
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - Ibrutinib
  - Pirtobrutinib
  - Ca2+
---
